Letter: the ethics of using inferior regimens in H. pylori randomised trials - invited comment

Comment

J P Anthony O'Connor et al. Aliment Pharmacol Ther. 2012 Apr.

. 2012 Apr;35(7):854-6; discussion 858.

doi: 10.1111/j.1365-2036.2011.04951.x.

No abstract available

Comment on

Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
Kim YS, Kim SJ, Yoon JH, Suk KT, Kim JB, Kim DJ, Kim DY, Min HJ, Park SH, Shin WG, Kim KH, Kim HY, Baik GH. Kim YS, et al. Aliment Pharmacol Ther. 2011 Nov;34(9):1098-105. doi: 10.1111/j.1365-2036.2011.04843.x. Epub 2011 Sep 19. Aliment Pharmacol Ther. 2011. PMID: 21923713 Clinical Trial.
Letter: the ethics of using inferior regimens in H. pylori randomised trials.
Graham DY, Fischbach LA. Graham DY, et al. Aliment Pharmacol Ther. 2012 Apr;35(7):852-4; discussion 858. doi: 10.1111/j.1365-2036.2011.04944.x. Aliment Pharmacol Ther. 2012. PMID: 22404411 No abstract available.